2021 VICTORIAN SYMPOSIUM Life as a Clinician-Scientist

Saturday 31 July About the Academy

The Australian Academy of Health and Medical Sciences is the impartial, authoritative, cross-sector voice of health and medical science in . We are an independent, interdisciplinary body of 425 Fellows – elected by their peers for their distinguished achievements and exceptional contributions to health and medical science in Australia. Collectively, they are a representative and independent voice, through which we engage with the community, industry and governments.

The Academy is uniquely positioned to convene cross-sector stakeholders from across Australia to address the most pressing health challenges facing society.

We focus on the development of future generations of health and medical researchers, on providing independent advice to government and others on issues relating to evidence based medical practice and medical researchers, and on providing a forum for discussion on progress in medical research with an emphasis on translation of research into practice.

The Academy is registered with the Australian Charities and Not-for-profits Commission (ACNC) and in endorsed as a deductible gift recipient. www.aahms.org

@MedSciAcademy @AAHMS_Health Welcome to Life as a Clinician-Scientist

Today we welcome you to showcase Life as a Clinician-Scientist. Our speakers will share their unique journeys that have led to a rich and rewarding career, filled with challenge and discovery. Why consider life as a clinician-scientist? Clinician-scientists have a unique and irreplaceable set of skills, enabling them to marry key clinical questions with insights into human biology. Medicine integrated with science allows you to take clinical observations and curiosities from the bedside, to answer deeper scientific questions, and translate these to have far reaching impact on improving patients’ lives. This diverse and exciting career involves collaboration with multidisciplinary teams of scientists and clinicians, in Australia and around the world. While medical research is challenging, with negative outcomes par for the course, such a career promises unlimited opportunities to create your own niche and pursue your passions. The Australian Academy of Health and Medical Sciences was established in 2014 to provide an impartial and authoritative voice for health, informed by the highest quality evidence and expert advice from the best and brightest in health and medical research. The Academy’s mission is also to grow and mentor Australia’s future generations of clinician-scientists and today’s symposium is aiming to do just that. We are honoured that such a group of consummate clinician-scientists has generously agreed to share their wisdom and expertise. We are also very grateful to our event sponsors for helping to facilitate this symposium highlighting these fascinating careers. We encourage you to join the twitter conversation by tagging the @AAHMS_Health handle. We hope the AAHMS Victorian symposium, Life as a Clinician-Scientist: The Best of Both Worlds, inspires you to consider becoming a clinician-scientist in the years ahead.

Professor Ingrid Scheffer President, AAHMS

Dr Alanna Rottler Physician Trainee

Co-convenors of the 6th Victorian LACS symposium

Thank you to our sponsors: 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM

Image of AAHMS President, Ingrid Scheffer, who is symposium chair. “You have three careers in a day – a doctor, a scientist and a teacher”

Laureate Professor Ingrid Scheffer AO FRS FAA FAHMS President, Australian Academy of Health and Medical Sciences Chair of Paediatric Neurology Research, The University of and Florey Institute of Neuroscience and Mental Health

4 Australian Academy of Health and Medical Sciences 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM PROGRAM SATURDAY 31 JULY 2021

8.30 am Registration SESSION 1 WHERE MEDICINE MEETS SCIENCE - WHAT IS A CLINICIAN-SCIENTIST? Chaired by Professor Christina Mitchell AO FAHMS, Dean, Monash University 9.00 am Professor Ingrid Scheffer AO FAHMS Welcome President, Australian Academy of Health and Medical Sciences 9.10 am Keynote How to never be bored Professor Kathryn North AC FAHMS Director, Murdoch Children’s Research Institute, Paediatric neurologist 9.50 am Keynote The life of a surgeon-scientist Professor Stephen O’Leary FAHMS ENT surgeon, 10.30 AM Morning tea SESSION 2 THE HOW, THE WHAT AND THE WHY OF RESEARCH Chaired by Dr Alanna Rottler

11:00 AM Professor Rachelle Buchbinder AO FAHMS A career built on serendipity not planning Rheumatologist, Monash University & Cabrini Health

11:30 AM Professor Alex Hewitt A tale of two cities Ophthalmologist, University of Tasmania 12.00 PM Professor Eric Morand MBBS FRACP I wonder what I’ll be when I grow up? Head, School of Clinical Sciences, Monash University

12:30 PM Lunch

SESSION 3 LESSONS IN SCIENCE AND RESEARCH Chaired by Professor Flavia Cicuttini AM FAHMS 1:45 PM Associate Professor Margie Danchin The golden ticket to COVID vaccine uptake Paediatrician, Murdoch Children’s Research Institute and herd immunity

2:15 PM Professor Allen Cheng Where do you see yourself in 5 years? Infectious diseases physician, Monash University 2:45 PM Associate Professor Piero Perucca The journey of an early career researcher: Neurologist, University of Melbourne & Austin Health trials, tribulations, and jubilations

3:15 PM Afternoon tea

SESSION 4 PANEL DISCUSSION - CHALLENGES ALONG THE WAY Chaired by Professor Ingrid Scheffer AO FAHMS 3:45 PM Mr Dan Croagh Hepatobillary surgeon Dr Jessica Howell Gastroenterologist

Associate Professor Jake Shortt Dr Penelope Bryant Infectious diseases Haematologist 5:00 PM Event close

Australian Academy of Health and Medical Sciences 5 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM SPEAKERS

Professor Christina Mitchell AO FAHMS

Professor Christina Mitchell is a physician scientist who has made major contributions to the field of intracellular signalling and haematology. Her work has concentrated on the regulation of phosphoinositide signalling by the inositol polyphosphate 5-phosphatases. She has taught the molecular basis of human diseases and haematology to science, biomedical and medical students at Monash University and has played a major role in research leadership, building research teams, and infrastructure. She is currently Dean of the Faculty of Medicine Nursing and Health Sciences Monash University. The major research direction of her group is to characterise the metabolic pathways that regulate phosphoinositide signalling in human cancer. Her group was among the first to purify and clone the 5-phosphatases and to delineate the substrates for these important enzymes in cancer.

Professor Ingrid Scheffer AO FAHMS

Professor Ingrid Scheffer AO is a physician-scientist whose work as a paediatric neurologist and epileptologist at the University of Melbourne and Florey Institute has led the field of epilepsy genetics over more than 20 years, in collaboration with Professor Samuel Berkovic and molecular geneticists. This resulted in identification of the first epilepsy gene and many more genes subsequently. Professor Scheffer has described many novel epilepsy syndromes and performed genotype–phenotype correlation. She recently played a key role in the first major reclassification of the epilepsies in two decades as Chair of the International League Against Epilepsy Commission for Classification and Terminology. She obtained her medical degree from Monash University and her PhD from the University of Melbourne for which she received the Chancellor’s Award. She trained in paediatrics at the Royal Children’s Hospital in Melbourne, paediatric neurology at The Great Ormond Street Hospital for Sick Children, London UK, and epileptology at the Austin Hospital. In her PhD on the genetics of the epilepsies, she described four novel epilepsy syndromes which served as the basis for gene discovery. She has received many awards: 2007 American Epilepsy Society Clinical Research Recognition Award, 2009 RACP Eric Susman Prize, 2013 GSK Award for Research Excellence, ILAE Ambassador for Epilepsy Award, 2013 Australian Neuroscience Medallion, 2013 Emil Becker Prize for child neurology and the L’Oréal-UNESCO Women in Science Laureate for the Asia-Pacific region for 2012. In 2014, she was elected as a Fellow of the Australian Academy of Sciences. She was awarded the Order of Australia in 2014 for “distinguished service to medicine in the field of paediatric neurology as a clinician, academic and mentor, and to research into the identification of epilepsy syndromes and genes.” Together with Professor Sam Berkovic, she was awarded the 2014 Prime Minister’s Prize for Science.

6 Australian Academy of Health and Medical Sciences 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM SPEAKERS

Professor Kathryn North AC FAHMS

Professor Kathryn North AC is Director of the Murdoch Children’s Research Institute and the David Danks Professor of Child Health Research at the University of Melbourne. Professor North is trained as a paediatric physician, neurologist and clinical geneticist and was awarded a doctorate for research in neurogenetics. She completed a postdoctoral fellowship in the Harvard Genetics Program. Professor North is a national and global leader in genomic medicine. She leads Australian Genomics, an NHMRC-funded national network of 80 institutions around Australia, with the goal of developing evidence and practical strategies to embed genomic medicine in the Australian health system. She is Vice Chair of the Global Alliance for Genomics and Health, a collaborative network of over 500 organisations across100 countries. Professor North served as Chair of the NHMRC Research Committee from 2012-2018, and currently chairs the International Advisory Board of the UCL Great Ormond Street Institute of Child Health (UK). She has received a number of awards for her research including the GSK Australia Award for Research Excellence (2011), the Ramaciotti Medal for Excellence in Biomedical Research (2012)and a Member (AM) of the Order of Australia (2012). In 2014 she was appointed as a Foundation Fellow of the Australian Academy of Health and Medical Science and in 2019 she was awarded a Companion (AC) of the Order of Australia in recognition of her eminent service to genomic medicine and medical research.

Professor Stephen O’Leary FAHMS

Professor Stephen O’Leary is the William Gibson Chair in Otolaryngology at the University of Melbourne.He has had a career long passion to improve hearing for those with a hearing loss. He has made significant clinical and scientific contributions to cochlear implantation, drug delivery to the inner earband surgical training technologies. Professor O’Leary’s clinical appointment is to the Cochlear Implant and Otology Clinics of the Royal Victorian Eye and Ear Hospital.

Dr Alanna Rottler

Dr Alanna Rottler is a basic physician trainee at Northern Health with an interest in neurology. Graduating from Monash University with an MBBS and a Bachelor of Medical Sciences, she has a passion for research and translating research into evidence-based public policy. She liaised with the Therapeutic Goods Agency regarding amendments to the Therapeutic Goods Act and contributed to the GenePool Productions documentary “Vitamania” following her research into the regulations of complementary medicines in Australia. Her passion for refugee health has seen her involved in research in primary health care for refugee health research and she has collaborated on a report to the World Health Organisation on addressing the health needs for migrants and refugees. She is currently involved in the investigation of the relationship between neutrophilia and different types of seizures with the Department of Neurology at Northern Health.

Australian Academy of Health and Medical Sciences 7 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM SPEAKERS

Professor Rachelle Buchbinder AO FAHMS

Professor Rachelle Buchbinder combines rheumatology practice with clinical research. She is supported by an NHMRC L3 Investigator fellowship, and is the inaugural Director, Monash-Cabrini Dept Musculoskeletal Health and Clinical Epidemiology, and a Professor in the Monash University Dept Epidemiology and Preventive Medicine, Monash University. She is known internationally as a vocal proponent of evidence-based medicine and for her landmark studies, particularly those examining treatments accepted into practice before proper evaluation. She has published more than 600 scientific papers and is in the top 0.1 per cent of the world’s most cited scientists. She was appointed an Officer of the Order of Australia (AO) for services to epidemiology and rheumatology in 2020. She led the establishment of the Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network and is its inaugural Chair; and she has been Coordinating Editor, Cochrane Musculoskeletal since 2005. Her book, “Hippocrasy, how doctors are betraying their oath”, written with Professor Ian Harris (a Sydney-based orthopaedic surgeon) and with support from a Rockefeller Foundation writing fellowship at the Bellagio Center in Italy, will be released 1 October, 2021.

Professor Alex Hewitt

Professor Alex Hewitt is a Principal Research Fellow at the Menzies Institute for Medical Research at the University of Tasmania, as well as a Principal Investigator at the Centre for Eye Research Australia. His major research interests lie in the ophthalmic applications of stem cell and gene-editing technology. Alex obtained his PhD investigating the molecular and phenotypic associations for glaucoma from Flinders University of South Australia in 2009, and completed formal ophthalmology training at the Royal Victorian Eye and Ear Hospital two years later. After undertaking a fellowship in inherited eye diseases at the Lions Eye Institute in Perth, Alex returned to Melbourne and with Prof Alice Pébay commenced the large-scale banking of cell lines from patients with and without a variety of eye diseases. Together they established a laboratory for automated processing of induced pluripotent stem cells. In 2014, Alex expanded his laboratory to Hobart, where his team have been applying CRISPR/Cas-gene editing technology to better understand and treat inherited eye diseases. He led the first report of viral mediated CRISPR/Cas editing in the retina. In 2016 and 2018, he received an NHMRC Research Excellence Award, for the top ranked Practitioner Fellowship application and Program Grant application.

8 Australian Academy of Health and Medical Sciences 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM SPEAKERS

Professor Eric Morand

Professor Eric Morand MBBS (Hons), FRACP, PhD, graduated from medicine at Monash University, trained in clinical rheumatology in Australia and at the Royal National Hospital for Rheumatic Diseases, UK and took his PhD at Monash University. His laboratory research focuses on glucocorticoid-induced proteins in the immune system, and his clinical research on systemic lupus erythematosus. He founded the Lupus Clinic at Monash Health, and the Asia Pacific Lupus Collaboration, now among the largest longitudinal cohorts of SLE patients ever assembled. He chaired the 2017 International Congress on SLE, and awards include the William E Paul Distinguished Innovator Award of the Lupus Research Alliance, New York, Dean’s Award for Research Excellence, and the Parr Prize of the Australian Rheumatology Association.

Professor Flavia Cicuttini AM FAHMS

Professor Flavia Cicuttini MBBS, FRACP, PhD, MSc, FAFPHM, is a rheumatologist and epidemiologist. She is the Alfred Hospital Head of Rheumatology, Head of the Musculoskeletal Unit at Monash University, and an NHMRC Investigator Leadership Fellow. Her principle research interests are the prevention and treatment of musculoskeletal diseases. Her awards include the Australian Rheumatology Association Parr prize (2010) and the President’s award (2015), Telstra Business Women’s Awards Finalist (2012), and Altmetric top 100 globally award (2019). She has published over 570 peer reviewed papers, cited more than 41090 times. She currently serves on the AIHW National Arthritis and Musculoskeletal Monitoring Advisory Group, the Repatriation Medical Authority, the Board of the Osteoarthritis Research Society International 2019-, and on the editorial board of a number of journals.

Associate Professor Margie Danchin

Professor Margie Danchin is a consultant paediatrician at the Royal Childrens Hospital and an Associate Professor and Clinician Scientist, University of Melbourne and Murdoch Childrens Research Institute (MCRI). As leader of the Vaccine Uptake Group, MCRI, her research focuses mainly on vaccine confidence, acceptance and uptake, particularly amongst high risk-groups and in low and middle-income countries. In Australia, she is the chair of the Collaboration on Social Science in Immunisation Group, chair of the Social Science Advisory Board and a member of the Scientific Advisory Committee, National Centre for Immunisation Research and Surveillance and on the COVID-19 ATAGI working group. She works closely with WHO and Global Vaccine Demand Hub and is part of the Melbourne Children’s Global health Leadership team, is a member of Sabin’s Vaccine and Acceptance Research Network steering group and the IPA-Vaccine Trust Project. She is working closely with the Victorian Department of Health on strategies to achieve high COVID-19 vaccine uptake.

Australian Academy of Health and Medical Sciences 9 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM SPEAKERS

Professor Allen Cheng

Professor Allen Cheng is Professor of Infectious Diseases Epidemiology and Director of the Infection Prevention and Healthcare Epidemiology unit at Alfred Health. His research covers a diverse area within infectious diseases, including sepsis and severe melioidosis, tropical medicine, influenza and vaccine effectiveness, hospital infection prevention and control, antibiotic pharmacokinetics, antimicrobial drug policy and clinical infectious diseases. He has published more than 280 peer-reviewed scientific publications (as well as more than 50 letters/editorials and 17 book chapters). Professor Cheng is current Vice-President of the Australasian Society for Infectious Diseases; he was the primary author for national guidelines for H1N1/09 influenza and Clostridium difficile infection; a foundation member of the Clinical Research Network of ASID; a steering committee member for the National Prescribing Service Antibiotic Resistance initiative; and a member of expert writing groups for Therapeutic Guidelines: Antibiotic and Respiratory. He is a member of the Expert Advisory Group revising the Australian Infection Control Guidelines for NHMRC. He is current Chair of the Advisory Committee for Vaccines and a previous member of the Advisory Committee on Prescription Medicines (advising the Therapeutic Goods Administration on vaccine and drug regulation issues), and Co-Chair of the Australian Technical Group on Immunisation. He is also a member of the National Influenza Surveillance Committee. He has also been a technical advisor to the World Health Organisation, resulting in drafting of international guidelines for management of sepsis and for severe H1N1/09 infection.

Associate Professor Piero Perucca

Associate Professor Piero Perucca, MD, PhD, FRACP is Associate Professor of Adult Epilepsy at the Department of Medicine (Austin Health), Melbourne Medical School, The University of Melbourne, and Director of the Comprehensive Epilepsy Program at Austin Health. He is also Adjunct Associate Professor at the Department of Neuroscience, Central Clinical School, Monash University, and holds honorary appointments at The Royal Melbourne Hospital and Alfred Health. He received his MD and specialist-in-neurology degrees from the University of Pavia, Italy. He undertook higher training in epilepsy at Columbia University, USA; University Hospitals Cleveland Medical Center, Case Western Reserve University, USA; the Montreal Neurological Institute, McGill University, Canada; and The Royal Melbourne Hospital. He obtained his PhD from the University of Melbourne, with a thesis focused on the role of genetics in the aetiology of focal epilepsies and outcomes of epilepsy therapy. His research program covers different areas of epileptology, including the genetics of epilepsy, electroencephalography, the pharmacological and surgical treatment of epilepsy, and pregnancy and epilepsy. He has published widely in field of epilepsy and has received several awards/prizes for his research, including the 2021 Leonard Cox Award from the Australian & New Zealand Association of Neurologists and the 2019 Young Researcher of the Year Award from the Bethlehem Griffiths Research Foundation. He is Chair of the Victorian Epilepsy Centres, and serves on committees of different scientific organisations, including the International League Against Epilepsy, the American Epilepsy Society, and the Epilepsy Society of Australia. He is also Associate Editor for Epilepsia Open.

10 Australian Academy of Health and Medical Sciences 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM SPEAKERS

Mr Dan Croagh

Mr Croagh is a pancreatic surgeon and researcher at Monash Health and Monash University. He completed a PhD at Peter Mac in 2007 exploring oesophageal stem cells. After a fellowship at the Queen Elizabeth Hospital in Birmingham on the HPB and Interventional Endoscopic Units, he returned to Monash Health in 2011 as a full time surgeon endoscopist, and to Monash University as a lecturer in 2013. As part of his interest in the management of pancreatic cancer he is the clinical lead for the pancreatic module of the Upper GI Cancer Registry and he established a Victorian Pancreatic Cancer Biobank which has collected tissue from ~ 400 patients with pancreatic cancer over the last five years, predominantly at Monash Health but also at Cabrini, Epworth, The Alfred and Peninsula Health. He has been exploring the potential role of EUS FNA for the molecular profiling of pancreatic cancer to improve the diagnostic accuracy of this technique and to explore its potential role in guiding personalised therapy.

Associate Professor Jake Shortt

Associate Professor Shortt is consultant haematologist at Monash Health and Head of Haematology Research at the School of Clinical Sciences, Monash University. He completed joint specialty training in clinical and laboratory haematology at the Alfred Hospital in 2008 before undertaking a PhD in cancer therapeutics at Peter MacCallum Cancer Centre. Upon completion of his PhD in 2011 he was awarded the Victorian Cancer Agency and Snowdome Foundation Erdi Fellowship to continue postdoctoral research focusing on epigenetic therapies in lymphoid cancer. In 2015 he was recruited to lead haematology research within the Monash Health Translation Precinct where he established the Blood Cancer Therapeutics Laboratory. Now supported by a Medical Research Future Fund ‘Next Generation Clinician Researcher Fellowship’, Associate Professor Shortt’s research program includes preclinical, translational and clinical projects. In addition to identifying and validating new therapeutic targets, his laboratory conducts genomic research on patient material sourced through investigator-initiated trials. He has acted as a Principal Investigator on more than 30 clinical trial protocols, spanning the full spectrum from first in human to international phase three studies. In addition to these research activities, Associate Professor Shortt is Chair of the Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Sciences Working Party, Deputy Chair of the ALLG Scientific Advisory Committee and a member of the Cancer Council Standing Research Subcommittee.

Australian Academy of Health and Medical Sciences 11 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM SPEAKERS

Dr Jessica Howell

Dr Howell is a consultant gastroenterologist and hepatologist at St Vincent’s Hospital Melbourne, specialising in viral hepatitis and liver cancer. She is also CR Roper Fellow (Department of Medicine, University of Melbourne) and head the Hepatitis B and Liver Cancer Working Group at Burnet Institute, leading a program of cross- institutional public health research to achieve hepatitis B elimination and reduce global mortality from liver cancer. After completing a translational immunology PhD in hepatitis C recurrence post liver transplantation (University of Melbourne), she pursued an NHMRC Sidney Sax fellowship at Imperial College London in epidemiology and public health, leading several international studies on biomarkers in liver cancer and hepatitis B in Africa (including novel applications of ctDNA). She also completed a Masters Epidemiology and Post Graduate Diploma of Public Health at the prestigious London School of Hygiene and Tropical Medicine (University of London, UK). She combines clinical, basic science, epidemiological and public health expertise in translational research projects in liver cancer and viral hepatitis, focused on marginalized populations including people who inject drugs and people from culturally and linguistically diverse communities. She currently leads several national and international multi-centre studies in novel diagnostics and biomarker development, health systems research and epidemiology in liver cancer and viral hepatitis. Her research program has generated 80 publications and over $22 million in research grant funding. She is a faculty member for ALA/ GESA and IVHEM; and is a regular invited panel member for multiple national and international clinical guidelines and technical advisor to the WHO (WPRO).

Dr Penelope Bryant

Dr Penelope Bryant is a paediatric infectious disease physician and general paediatrician who has trained and worked in the UK and Australia. She is the medical lead of Hospital in the Home at the Royal Children’s Hospital Melbourne. She is group leader of the Murdoch Children’s Clinical Paediatrics group, and with the support of an MRFF Investigator Grant she researches improving use of antibiotics in children and ways to treat children safely at home. She juggles clinical work, research, a few smiley children, occasional forays into Lego animation and most recently has added secondment to the Department of Health to support COVID contact tracing into the mix.

12 Australian Academy of Health and Medical Sciences 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM SPONSORS

Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation. With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities. As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences. At Monash Medicine, Nursing and Health Sciences, our translational model enables the work we do every day as we break through new frontiers of scientific understanding to improve global health and propel future research and educational excellence. For more information, visit www.monash.edu/medicine

The University of Melbourne is a global leader in higher education where brilliant minds come together to address important questions and tackle grand challenges. We equip our students with a future-facing education personalised around their ambitions, enriched by global perspectives and embedded in a collaborative research culture. As active citizens and future leaders, they represent our greatest contribution to the world. We engage our communities to ensure that education and research is inspired by need and for the benefit of society. In this, we remain true to our purpose and will fulfil our mission as a public-spirited institution dedicated to the principles of fairness, equality and excellence in everything we do.

The Centre for Eye Research Australia is an independent Medical Research Institute, proudly affiliated with the University of Melbourne. We are based at the Royal Victorian Eye and Ear Hospital in Melbourne. We are deeply committed to conducting eye research with real-life impact and finding ways to prevent people from going blind. As an international leader in eye research – ranking in the world’s top 5 for ophthalmology research – we use our world-class knowledge and expertise to achieve better treatments and faster diagnosis of eye disease. Our goal is to prevent vision loss – and ultimately, find cures to restore sight. As true innovators our scientists are on the brink of new discoveries every day. With CERA, there’s hope in sight.

Australian Academy of Health and Medical Sciences 13 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM SPONSORS

Improving health through breakthrough scientific discovery A global bioscience medical research leader, Hudson Institute’s sole focus is on powering ground-breaking scientific discoveries into clinical outcomes. Our 450 scientists and students push the boundaries of knowledge to solve complex problems around human disease across inflammation, cancer, infant and child health, reproductive health and pregnancy and hormones. Research at Hudson Institute spans the entire medical field, from discovery and translational research to clinical trials. Located within a major scientific research and medical innovation hub in Melbourne’s south-eastern corridor, our Precinct is a hub for biomedical research translation transforming health care. With our precinct partners, Monash University, Monash Health and Monash Children’s Hospital, we deliver outstanding healthcare, education and leading research. Our Translational Research Facility (TRF) accelerates scientific discovery by bringing together scientists and clinicians supported by state-of-the-art laboratories, world leading technology platforms and a clinical trials centre.

Graduate education More than 180 students are mentored by our senior researchers and clinician- researchers. A link-bridge connecting the TRF to the Monash Medical Centre and Monash Children’s hospital and provides crucial flow during education between patients, clinicians, scientists and new potential therapies. As productive members of world-class research groups, our students publish scientific papers, while the larger open structure of collaboration supports expanded thinking to pursue discoveries and publish innovative work. Our students are predominantly enrolled through our on-site partner, the School of Clinical Sciences at Monash Health, part of the Faculty of medicine, Nursing and Health Science at Monash University.

Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why the University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning – partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.

14 Australian Academy of Health and Medical Sciences 2021 VICTORIAN CLINICIAN-SCIENTIST SYMPOSIUM SPONSORS

Discoveries that transform child health

We are addressing some of the biggest issues surrounding child health worldwide, across a diverse set of specialities. Our world-leading researchers aim to translate discoveries into effective prevention, early intervention approaches and treatments for common and rare childhood conditions, to make a difference to the lives of children and young people globally. Our partnership with The Royal Children’s Hospital and The University of Melbourne allows us to rapidly translate discoveries in laboratory, clinical and public health research into real benefits to help children live healthier, happier lives. This is why the Murdoch Children’s Research Institute is the place to be to change the face of child health.

As one of Australia’s leading tertiary education providers, Deakin offers a personalised experience enhanced by world-class programs and innovative digital engagement. We lead by creating opportunities to live and work in a connected, evolving world.

WEHI (the Walter and Eliza Hall Institute) is a medical research institute the world’s brightest minds collaborate and innovate to make discoveries that improve our community’s health. Our researchers – including clinician-scientists – make transformative discoveries for cancer, infectious and immune diseases, developmental disorders and healthy ageing. We work collaboratively, with multidisciplinary teams tackling important questions in medical research. Clinician-scientists are valued members of WEHI’s research teams, and we offer opportunities for medical students and graduates to gain research skills through undergraduate and postgraduate (PhD) programs, and also as postdoctoral researchers and laboratory heads.

Australian Academy of Health and Medical Sciences 15 Australian Academy of Health and Medical Sciences 411 Vulture Street, PO Box 6114, Woolloongabba, QLD 4102 Woolloongabba, QLD 4102 Australia Australia

www.aahms.org | [email protected] | T: +61 (0) 7 3102 7220

AAHMSABN: Annual 55 Meeting 167 124 | October 067 2019

16 Australian Academy of Health and Medical Sciences